checkedHuberman Lab2026-11-05last verified 2026-11-06

does inflammation raise the risk of depression, anxiety and alzheimer's disease?

verdict: overstated
directionally right; magnitude or certainty inflated
“that inflammation increases the risk of depression and anxiety and Alzheimer's disease”

a guest, Dr. Susanna Søberg, researcher on cold and heat exposure said on Huberman Lab, 2026-11-05, at 31:05. hear it in context → the speaker cited: newer research (unnamed).

first, the part that holds

for depression, the claim holds up. higher inflammatory markers come before later depression in long-term studies, and genetic evidence points to the IL-6 signaling pathway as a plausible cause, not just a bystander.

what we found when we went and looked

we went and looked at four primary records. in a UK cohort, children in the top third of IL-6 at age 9 had higher odds of depression at 18 (adjusted OR 1.55, 95% CI 1.13-2.14), and in up to 144,890 UK Biobank adults, genetically higher IL-6 activity was linked to depressive symptoms (OR 1.32, 1.03-1.67). anxiety is weaker: its observational link was small (OR 1.03 per log unit of CRP), and genetically higher IL-6 had no clear effect on anxiety (OR 1.11, 0.90-1.37). for alzheimer's disease specifically, a meta-analysis found a modest CRP signal (HR 1.21) and no IL-6 signal (HR 1.06, 0.83-1.35), and a 111,242-person cohort found that low CRP, not high, predicted alzheimer's. so the claim is right on depression, stretched on anxiety, and not established for alzheimer's.

assertion by assertion

assertionverdictwhat the record says
systemic inflammation increases the risk of developing depressionconfirmedin a population birth cohort, children in the top vs bottom third of IL-6 at age 9 had higher odds of depression at 18 (adjusted OR 1.55, 95% CI 1.13-2.14), though CRP showed no association. in UK Biobank, a genetic (mendelian randomization) analysis linked higher IL-6 activity to depressive symptoms (OR 1.32, 95% CI 1.03-1.67). limitation: the effects are modest, the signal depends on the marker, and genetically higher CRP pointed the other way (OR 0.89, 0.79-1.00). [1]
systemic inflammation increases the risk of developing anxietyoverstatedin UK Biobank, CRP was associated with anxiety, but weakly (OR 1.03 per log unit; top vs bottom fifth OR 1.12), and that association was measured at a single time point, not over time. in the genetic analysis, IL-6 activity had no clear effect on anxiety symptoms (OR 1.11, 0.90-1.37), and genetically higher CRP went with lower anxiety risk (OR 0.88, 0.79-0.97). the authors found every association weaker for anxiety than for depression. [1]
systemic inflammation increases the risk of alzheimer's diseaseoverstateda meta-analysis of 7 prospective studies (5,717 people) found higher CRP linked to all-cause dementia (HR 1.45) and only modestly to alzheimer's disease (HR 1.21, 1.03-1.42); IL-6 was not associated with alzheimer's (HR 1.06, 0.83-1.35). the authors call the evidence for alzheimer's alone 'limited'. a 111,242-person Copenhagen cohort found the reverse: the lowest CRP went with higher alzheimer's risk (HR 1.69, 1.29-2.16), and genetic data backed that up in people with BMI of 25 or lower. [2][3]
popular framing: a high CRP blood test means a person is on the way to these conditionsmisattributedthe associations are population-level and small: in the depression meta-analytic and cohort literature, single markers explain little of individual risk. CRP in particular behaves inconsistently: it predicts depression in some observational data, but genetically higher CRP is linked to lower depression and anxiety risk and, in one large cohort, low CRP predicted alzheimer's. any causal signal so far sits in the IL-6 pathway, not in CRP itself. [1][3]

both directions

for the speaker: for depression, the evidence runs both ways the claim needs. inflammation measured in childhood predicts depression years later (IL-6 adjusted OR 1.55), and in UK Biobank, genetically higher IL-6 activity was linked to depressive symptoms (OR 1.32), which the authors read as a potential causal role for the IL-6 pathway. for dementia overall, higher CRP and IL-6 were each associated with modestly higher risk (HR 1.45 and 1.32). so the speaker is describing a real research direction, not an invention.

against: the claim lists three conditions as if the evidence were equal. it is not. for anxiety, the observational link was small and measured at a single time point, and the genetic tests found no IL-6 effect plus a protective-looking CRP effect. for alzheimer's disease specifically, IL-6 showed no association in the meta-analysis, the CRP signal was modest, and a 111,242-person cohort found that low CRP, not high, came before alzheimer's. the dementia signal belongs mostly to all-cause dementia, which includes vascular dementia, not to alzheimer's. even for depression, the CRP genetic result points the opposite way, so 'inflammation' cannot be treated as one thing.

what this cannot say

'inflammation' is measured through a few blood markers, mostly CRP and IL-6, and they don't agree with each other. mendelian randomization assumes the genetic variants affect the outcome only through the marker, and IL-6 receptor variants may not mimic lifelong low-grade inflammation. the cohorts are mostly white and european. the anxiety data we read is cross-sectional for the observational part. the speaker named no specific study, so we cannot tell which 'newer research' was meant. we read four records, not a full systematic review. a 2013 longitudinal meta-analysis on CRP, IL-6 and depression could not be loaded in this session, so we did not cite it.

sources, each one fetched and read

  1. Role of inflammation in depression and anxiety: tests for disorder specificity, linearity and potential causality of association in the UK Biobank. EClinicalMedicine, 2021 What we read there: observational CRP: depression OR 1.09 per log unit, anxiety OR 1.03; genetic analysis: IL-6 activity and depressive symptoms OR 1.32 (1.03-1.67), anxiety OR 1.11 (0.90-1.37); genetically higher CRP and depression OR 0.89 (0.79-1.00), anxiety OR 0.88 (0.79-0.97). Fetched 2026-11-06 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC8413248/
  2. The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis. Journals of Gerontology Series A, 2013 What we read there: 7 studies, 5,717 participants; CRP and all-cause dementia HR 1.45 (1.10-1.91), IL-6 HR 1.32 (1.06-1.64); for alzheimer's disease CRP HR 1.21 (1.03-1.42), IL-6 HR 1.06 (0.83-1.35); 'evidence for an association with risk of AD alone is limited.' Fetched 2026-11-06 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC3693673/
  3. C-reactive protein levels and risk of dementia: observational and genetic studies of 111,242 individuals from the general population. Alzheimer's & Dementia, 2022 What we read there: lowest vs reference CRP: alzheimer's disease HR 1.69 (1.29-2.16), all-cause dementia HR 1.60 (1.29-1.97), robust to excluding up to 10 years of follow-up; genetically low CRP linked to higher alzheimer's risk in people with BMI of 25 or lower (HR 1.93). Fetched 2026-11-06 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC9790296/

speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam